BODI Bodisen

TIDMBODI

RNS Number : 6572A

Bodisen Biotech Inc

24 December 2014

24 December 2014

Bodisen Biotech, Inc.

("Bodisen" or the "Company")

Cancellation of Admission to Trading on AIM

Bodisen announced on 24 June 2014 that the Company had been unable to publish its audited results for the year ended 31 December 2013 and accordingly, the Company's ordinary shares were suspended from trading on AIM.

The Company remains unable to confirm when the audit for the year to 31 December 2013 will be completed or when the accounts will be published.

As a result, and in accordance with AIM Rule 41, admission of the Company's shares to trading AIM will be cancelled on 29 December 2014 at which point the Company's shares will have been suspended from trading for six months.

Bodisen shares continue to be traded on the OTC market in the United States (ticker: BBCZ).

Charles Stanley Securities confirms that it will resign as the Company's Nominated Adviser and Broker with effect from 29 December 2014.

Enquiries:

Bodisen Biotech, Inc.

Lin Wang 0086 29 8707 4957

Charles Stanley Securities

(Nominated Adviser)

Russell Cook / Carl Holmes 020 7149 6000

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRPGGMPPUPCGMW

Bodisen Biotech (LSE:BODI)
Historical Stock Chart
From Apr 2024 to May 2024

Bodisen Biotech (LSE:BODI)
Historical Stock Chart
From May 2023 to May 2024